Marin, Concepció https://orcid.org/0000-0001-8478-7477
Alobid, Isam
Fuentes, Mireya
López-Chacón, Mauricio
Mullol, Joaquim
Article History
Accepted: 13 January 2023
First Online: 25 January 2023
Compliance with Ethical Standards
:
: C. Marin declares that she has no conflict of interest. I. Alobid has received speaker and consultancy honoraria from Viatris, Roche, Sanofi, GSK, MSD, Menarini, Salvat and Novartis. M. Fuentes declares that she has no conflict of interest. M. López-Chacón declares that he has no conflict of interest. J. Mullol has received speaker and consultancy honoraria, and grants from Sanofi-Genzyme & Regeneron, Novartis, Viatris, Uriach Group, Mitsubishi-Tanabe, Menarini, UCB, AstraZeneca, GSK and MSD.
: This article does not contain any studies with human or animal subjects performed by any of the authors.